COSCIENS Biopharma Inc. (CSCIF)

Market Cap	5.49M -33.6%
Revenue (ttm)	8.73M -3.0%
Net Income	6.55M
EPS	6.22
Shares Out	n/a
PE Ratio	0.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111
Open	5.50
Previous Close	n/a
Day's Range	5.50 - 5.50
52-Week Range	2.37 - 9.57
Beta	1.90
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About COSCIENS Biopharma

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important bi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 28
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSCIF

Financial Performance

In 2025, COSCIENS Biopharma's revenue was $7.50 million, a decrease of -21.79% compared to the previous year's $9.59 million. Losses were -$10.36 million, -32.34% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 14, 2026

Data Sources Report a data error